Patten & Patten’s Biogen BIIB Stock Holding History

Patten & Patten’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-850	Closed	-$359K	–	212
2015 Q1	$359K	Buy	+850	New	+$335K	0.05%	177
2014 Q1	–	Sell	-725	Closed	-$203K	–	263
2013 Q4	$203K	Buy	+725	New	+$188K	0.03%	242

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Patten & Patten's BIIB Position: Q2 2015 in Review

Patten & Patten sold out of Biogen (BIIB) in Q2 2015, closing a stake of 850 shares — an estimated $359K sold.

Patten & Patten first reported a position in BIIB in Q4 2013 and held it in 2 quarters. The position peaked at $359K in Q1 2015. 974 funds tracked by Wall St. Rank hold BIIB as of Q2 2015.

Patten & Patten reported no remaining Biogen position as of Q2 2015 after selling out during the quarter.
Patten & Patten sold 850 Biogen shares in Q2 2015, an estimated $359K.
Patten & Patten first reported a position in Biogen in Q4 2013 and held it in 2 quarters.
Patten & Patten's Biogen position peaked at $359K in Q1 2015.
974 funds tracked by Wall St. Rank held Biogen as of Q2 2015.

Based on Patten & Patten's 13F filing for Q2 2015, filed 31 Aug 2015.